Proceeds from the sale of “Titty Sprinkles” cannabis products will fund research and education
Good Day Farm (“Good Day Farm” or the “Company”), a leading medical cannabis producer with operations across the southern U.S., today announced a new partnership with Realm of Caring (“RoC”), a nonprofit dedicated to cannabinoid research, for Breast Cancer Awareness month. As part of the collaboration, a portion of the proceeds from the sale of Good Day Farm’s popular “Titty Sprinkles” product line will benefit RoC’s breast cancer research and education initiatives.
“We launched Titty Sprinkles to honor the millions of women – and their loved ones – affected by breast cancer. This strain is truly a labor of love, cultivated with the express purpose of supporting breast cancer research and awareness in the communities we serve,” said Laurie Gregory, Chief Marketing Officer, Good Day Farm. “For many breast cancer patients and survivors, medical cannabis is a life-changing tool for coping with their physical and psychological symptoms. This partnership enables us to support Realm of Caring’s growing body of cannabinoid research, including its usefulness for breast cancer patients.”
Titty Sprinkles | Good Day Farm
RoC maintains the nation’s largest cannabinoid research registry for tracking client conditions, user experience and outcomes – providing the basis for RoC’s peer-reviewed papers in collaboration with Johns Hopkins University. Patients visiting Good Day Farm dispensaries will be encouraged to contact RoC for free one-on-one consultations to assist in their cannabinoid therapy journey, from product selection to dosing guidance, as well as access to an extensive research library featuring over 800 peer-reviewed journal articles on medical cannabis searchable by condition and age group.
“Realm of Caring is all about improving lives through research, education and community,” said Sasha Kalcheff-Korn, Executive Director, Realm of Caring. “We have helped more than 80,000 clients to date, and we look forward to helping even more through Good Day Farm’s
growing customer base. There is so much therapeutic potential for cannabinoids in breast cancer and expanding our current registry may lead to improvements in care.”
Available in Arkansas and Missouri – and soon to launch in Louisiana – the Titty Sprinkles portfolio includes 3.5g of flower, two full flower pre-rolls known as Good Day J’s, and diamond and sauce supreme concentrate.
For more information about Good Day Farm or to find a dispensary near you, please visit
About Good Day Farm
Founded in 2020, Good Day Farm is the largest licensed medical cannabis producer in the South, supplying the region with an abundant selection of cannabis products in a diverse range of formats, including premium flower, edibles, vapes, concentrates, syringes, tinctures
and topical creams. With state-of-the-art grow operations and cutting-edge R&D facilities across Louisiana, Arkansas and Missouri, Good Day Farm prides itself on being an ambassador of this healing plant in the South, where every day the Company is on a relentless quest to grow, nurture and share really good cannabis. From high-touch and high-tech growing practices to expert extraction methods, everything Good Day Farm does is rooted in a desire to cultivate goodness – good people, good cannabis and good days. Good Day Farm is a proud partner of the Last Prisoner Project and continues to be a strong advocate for the plants over pills movement.
About Realm of Caring
Through research and education, Realm of Caring (RoC) is facilitating the mainstream acceptance of cannabinoid-based therapies and building an empowered community. RoC is committed to research into novel healthcare options to improve quality of life. The organization leverages a deep bench of experience and leads with compassion to provide trusted resources, create support and build community for all who seek it. The 501(c)(3) high-impact independent public charitable organization has served tens of thousands of families and healthcare professionals since its inception in 2013.
What do you think?